Gene therapy for hepatocellular carcinoma using sonoporation enhanced by contrast agents
- 13 May 2005
- journal article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 12 (11) , 884-889
- https://doi.org/10.1038/sj.cgt.7700850
Abstract
We examined whether sonoporation enhanced by a contrast agent (BR14) was effective in gene therapy for hepatocelluar carcinoma (HCC). Human hepatic cancer cells (SK-Hep1) and plasmid cDNAs expressing green fluorescent protein (GFP), interferon (IFN), and LacZ were used. In vitro, SK-Hep1 cell suspensions with DNA and BR14 were sonoporated. Expressions of every plasmid cDNA and the antitumor effect of IFN were analyzed. In vivo, GFP and IFN genes with BR14 were directly injected into subcutaneous tumors using SK-Hep1 in nude mice, and transcutaneous sonoporation of the tumors was performed. GFP gene transfections and tumor diameters after IFN gene transfection were examined. In vitro, no SK-Hep1 cells were transfected without sonication, whereas transfections were successful after sonication with BR14. Antitumor effect of IFN gene transfection by ultrasound (US) and with BR14 was revealed. In vivo, the SK-Hep1 cells expressed GFP, and the IFN gene transfection by US with BR14 reduced tumor size significantly. In conclusion, gene therapy with sonoporation enhanced by a contrast agent may become a new treatment option for HCC.Keywords
This publication has 37 references indexed in Scilit:
- Liposomal Enhancement of the Antitumor Activity of Conditionally Replication-Competent Adenoviral PlasmidsMolecular Therapy, 2004
- A nonviral carrier for targeted gene delivery to tumor cellsCancer Gene Therapy, 2003
- Combined suicide gene therapy for pancreatic peritoneal carcinomatosis using BGTC liposomesCancer Gene Therapy, 2003
- Long–Term Expression of Angiostatin Suppresses Metastatic Liver Cancer in MiceHepatology, 2003
- Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID miceHepatology, 2002
- Systemic Interleukin-6 Responses Following Administration of Adenovirus Gene Transfer Vectors to Humans by Different RoutesMolecular Therapy, 2002
- Local drug and gene delivery through microbubblesProgress in Cardiovascular Diseases, 2001
- Predictive factors of response to octreotide for the treatment of portal hypertensive ratsJournal of Hepatology, 2001
- Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the escherichia coli purine nucleoside phosphorylase geneHepatology, 2000
- The role of cytokines in mediating the bystander effect using HSV-TK xenogeneic cellsCancer Letters, 1995